ADICET BIO INC. - COMMON STOCK

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

19 Dec 2024 09:56:29 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

18 Dec 2024 15:52:58 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

22 Nov 2024 09:45:07 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

21 Nov 2024 10:03:24 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

15 Nov 2024 09:45:02 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

14 Nov 2024 14:54:25 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

03 Jul 2024 10:10:38 By NetDania Notify

NetDania - New 12 months Low: ADICET BIO INC. - COMMON STOCK

02 Jul 2024 14:40:17 By NetDania Notify

Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

10 Dec 2021 16:01:00 By Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock

08 Dec 2021 01:13:10 By Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock

07 Dec 2021 16:16:11 By Nasdaq GlobeNewswire

Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy

06 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkin’s Lymphoma

29 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors

18 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting

12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates

10 Nov 2021 16:01:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference

08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting

04 Nov 2021 09:00:02 By Nasdaq GlobeNewswire

Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer

12 Oct 2021 16:10:00 By Nasdaq GlobeNewswire

Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting

04 Oct 2021 07:00:00 By Nasdaq GlobeNewswire